Related content

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 174-179

Bentham Science Publishers

Access to resources Recommend Favorite

Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

By Recio F.O.   Piver M.S.   Hempling R.E.   Driscoll D.L.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer

By Zhao Jing   Chen Xinxiao   Zhang Aimu   Xu Feng   Hu Meilong   Xie Congying   Xue Shengliu  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-7

Humana Press, Inc

Access to resources Recommend Favorite

Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission

By Tournigand C.   Louvet C.   Molitor J.-L.   Fritel X.   Dehni N.   Sezeur A.   Pigne A.   Cady J.   Milliez J.   de Gramont A.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 341-345

Elsevier

Access to resources Recommend Favorite

Comprehensive treatment of advanced primary liver cancer with intraperitoneal chemotherapy or in combination with other therapies: therapeutic observation of 72 cases

By Shen Weifeng  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 69-71

Springer Publishing Company

Access to resources Recommend Favorite